Home » Healthcare » Rare Disease Genetic Testing Market

Rare Disease Genetic Testing Market By Next-Generation Sequencing (NGS) (Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES)); By Targeted Genetic Testing (Panel Testing, Single Gene Testing); By Non-Invasive Prenatal Testing (NIPT) (Screening for Genetic Disorders in the Fetus); By Carrier Screening (Identifying Carriers of Genetic Mutations); By Diagnostic Testing (Confirmatory Testing, Comprehensive Diagnostic Testing); By Preimplantation Genetic Testing (PGT) (Screening Embryos for Genetic Abnormalities); By Direct-to-Consumer (DTC) Genetic Testing (Consumer-Initiated Genetic Testing Services); By Technological Platforms (Microarray Technology, PCR (Polymerase Chain Reaction)); By Bioinformatics and Data Analysis (Interpretation Services, Data Storage and Management); By Bioinformatics and Data Analysis (Hospitals and Clinics, Genetic Testing Laboratories, Direct-to-Consumer Companies); By Region -Growth, Share, Opportunities & Competitive Analysis, 2023 – 2030

Price: $4999

Published: | Report ID: 32401 | Report Format : PDF

Market Insights

  • The global demand for Rare Disease Genetic Testing was valued at USD 894.8 million in 2022 and is expected to reach USD 2775.5 Million in 2030, growing at a CAGR of 15.20% between 2023 and 2030.
  • WES is currently the main category in this market, and WGS is another significant area.
  • The market demand governing segment is Panel Testing.
  • Identifying Genetic Mutation Carriers accounts for a sizable portion of the Rare Disease Genetic Testing Market.
  • Confirmatory Testing is an important market sector, and Comprehensive Diagnostic Testing has a sizable market share.
  • The Rare Disease Genetic Testing Market includes embryo screening for genetic abnormalities.
  • Consumer-Initiated Genetic Testing Services are becoming increasingly popular in the market.
  • The most important component is PCR, which is routinely used for amplifying specific DNA sequences and detecting genetic variations. Microarray technology is another important market segment.
  • The fastest growing market sector is data storage and management.
  • Hospitals and clinics have a bigger market share, and one of the market’s fastest-growing categories is genetic testing laboratories.
  • North America is expected to dominate the global market in 2022, accounting for more than 47.2% of the total, and Asia Pacific is expected to rise at the fastest rate.
  • The rising prevalence and acknowledgment of uncommon diseases drives market expansion.
  • Ethical and privacy issues about genetic testing stymie business expansion.

Rare Disease Genetic Testing Market

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Executive Summary

Market Definition

Genetic testing is a diagnostic technique that can help not only identify specific illness presentations but also determine the underlying causes of genetic disorders. Genetic testing has several advantages, including the ability to confirm a diagnosis, determine the reason of unexplained symptoms, and find treatment alternatives, including clinical trials. Genetic testing encompasses a wide range of uses, from collecting and analyzing family histories to screening the entire genome. Based on the technology utilized and the indication for the test, each test has its own set of advantages and disadvantages. A rare disease is a condition, disorder, or disease that affects only a small proportion of the population at any particular moment.

Market Overview

It is anticipated that between 2023 and 2030, the worldwide Rare Disease Genetic Testing Market will expand at a compound annual growth rate (CAGR) of 15.20%. From USD 894.8million in 2022, the market is projected to be worth USD 2775.5 million by 2030.

The Rare Disease The Genetic Testing Market is a fast expanding sector of the healthcare industry. It entails evaluating individuals for genetic abnormalities or changes linked to rare diseases. Several reasons are driving this market, including increased awareness and knowledge of rare diseases, developments in genetic testing technologies, and the rising availability and affordability of genetic testing services.

The market is distinguished by a diverse set of genetic testing methods, including targeted gene sequencing, whole exome sequencing, and whole genome sequencing. These tests aid in the identification of specific genetic anomalies that may be responsible for rare diseases, allowing for accurate diagnosis and individualized treatment regimens.

The benefits of rare illness genetic testing, such as early discovery, improved disease management, and the potential for targeted medicines, are driving up demand. Furthermore, the availability of genetic counselling services and the incorporation of genetic testing into standard healthcare procedures contribute to the market’s growth.

Segmentation by Next-Generation Sequencing (NGS)

  • WES is currently the dominant category in this market. WES focuses on solely the protein-coding sections of the genome, which are responsible for the vast majority of disease-causing mutations.
  • On the other hand, WGS sequences the entire genome, providing a more thorough picture of an individual’s genetic make-up. WGS is gaining popularity as the technology becomes more accessible and inexpensive.

Segmentation by Targeted Genetic Testing

  • Panel Testing is the market demand governing segment. Panel testing entails examining numerous genes linked to a certain set of diseases or ailments. It enables a more focused approach to determining the genetic etiology of a rare disease. Panel testing is favoured because it provides a complete study of numerous genes at the same time, saving time and money over single gene testing.

Segmentation by Non-Invasive Prenatal Testing (NIPT)

  • Screening for Genetic Disorders in the Fetus is a market sector in the Rare Disease Genetic Testing Market. This part focuses on genetic testing performed during pregnancy to detect probable genetic illnesses or chromosomal abnormalities in the developing fetus. It is critical in identifying conditions that may have an impact on the baby’s health after birth.

Segmentation by Carrier Screening

  • Identifying Genetic Mutation Carriers is a significant component of the Rare Disease Genetic Testing Market. It entails testing people to see if they have any genetic mutations that could be passed down to their children. This is especially important for people who are thinking about starting a family or who are already expecting a kid. Healthcare experts can provide crucial information regarding the danger of passing on certain genetic illnesses to future generations by identifying carriers of genetic abnormalities.

Segmentation by Diagnostic Testing

  • Confirmatory Testing, which entails doing further tests to confirm the presence of a certain genetic mutation or illness, accounts for the majority of the market. It is critical in giving precise and conclusive diagnoses, as well as ensuring that patients receive suitable treatment and management strategies.
  • On the other hand, Comprehensive Diagnostic Testing has a considerable market share due to its analysis of a wide variety of genes and genetic markers to discover potential genetic abnormalities.

Segmentation by Preimplantation Genetic Testing (PGT)

  • Embryo screening for genetic abnormalities is a significant sector of the Rare Disease Genetic Testing Market. This section entails performing genetic tests on embryos during the in vitro fertilization (IVF) process to detect any potential genetic abnormalities or chromosomal diseases.

Segmentation by Direct-to-Consumer (DTC) Genetic Testing

  • Consumer-Initiated Genetic Testing Services have grown in popularity in the market due to their ease of use and accessibility. Individuals can use these services to purchase genetic testing kits and receive results without contacting healthcare experts or traditional medical settings.

Segmentation by Technological Platforms

  • The dominant part is PCR, which is commonly employed for amplifying specific DNA sequences and detecting genetic variants. It is a useful tool for a variety of applications, including diagnostic testing, research, and forensic analysis. Because PCR allows for the amplification of a little amount of DNA, it is highly sensitive and effective in detecting genetic disorders or identifying specific DNA sequences.
  • Another significant market area is microarray technology.

Segmentation by Bioinformatics and Data Analysis

  • Data Storage and Management is the market’s fastest expanding segment. With the exponential growth of data across industries, there is a growing demand for efficient and secure storage solutions. Data Storage and Management refers to the technology and services that enable businesses to successfully store, organize, and manage their data.

Segmentation by End-User

  • Hospitals and clinics command a larger market share. Hospitals and clinics are the principal providers of healthcare and provide a wide range of medical services, including genetic testing.
  • On the other hand, Genetic Testing Laboratories are one of the market’s fastest-growing categories. These labs specialize in genetic testing and DNA analysis to provide vital insights into an individual’s genetic composition, prospective health risks, and individualized treatment alternatives.
  • Direct-to-Consumer Companies, while also expanding, are recent entrants in the sector.

Segmentation by Region

  • North America dominated the global industry in 2022, accounting for more than 47.2% of the total.
  • Asia Pacific is predicted to expand the fastest growth rate.
  • The rest of the world, including Latin America, the Middle East, and Africa, supplies the remaining demand for Rare Disease Genetic Testing.

Rare Disease Genetic Testing Market Research

North America dominated the global industry in 2022. The region’s dominant position can be linked to the region’s high incidence of rare diseases, a big number of disease registries, the availability of a significant number of R&D facilities for ultra-rare diseases, and extensive investments in disease detection.

On the other hand, Asia Pacific is expected to grow at the quickest rate throughout the projection period, with a CAGR of 18.1%. This is primarily due to increased awareness and diagnostic abilities. Furthermore, the implementation of disease control policies and procedures would provide attractive opportunities in this region. In India, for example, the Ministry of Health and Family Welfare approved an all-inclusive National Policy for Rare Diseases in March 2021. Furthermore, the Indian Council of Medical Research established a hospital-based National Registry for uncommon Diseases in 2017 by involving centres around the country involved in the management and diagnosis of uncommon diseases.

Key Highlights of the Report

The global Rare Disease Genetic Testing Market is segmented by Next-Generation Sequencing (NGS), Targeted Genetic Testing,  Non-Invasive Prenatal Testing (NIPT), Carrier Screening, Diagnostic Testing, Preimplantation Genetic Testing (PGT), Direct-to-Consumer (DTC) Genetic Testing, Technological Platforms, Bioinformatics and Data Analysis, End-User and region. WES is the dominating category in this market at the moment, and Panel Testing is the market demand ruling segment. In addition, embryo screening for genetic disorders is a big industry, and consumer-initiated genetic testing services have gained in popularity. Also, Data Storage and Management is the market’s fastest growing sector, with North America leading the market growth.

increased prevalence and awareness of rare diseases, developments in genetic testing technology and lower costs, and increased need for tailored therapy and focused therapies are the key drivers of the market. Moreover, ethical and privacy concerns related with genetic testing, as well as a complex regulatory environment and reimbursement challenges, are the key market limitations.

Nonetheless, In 2022, North America led the global industry. The region’s dominant position can be attributed to the region’s high incidence of rare diseases, a large number of disease registries, the presence of a large number of R&D centres for ultra-rare diseases, and major investments in disease detection. Furthermore, Asia Pacific is predicted to develop at the fastest rate during the projection period.

 What Elements Are Driving the Global Market for Rare Disease Genetic Testing?

Increasing the prevalence and recognition of rare diseases: As people become more aware of and understand rare diseases, there is a larger demand for accurate and timely diagnosis. This necessitates genetic testing to detect specific genetic mutations or variants linked to rare disorders. Furthermore, advances in genetic testing methods and lower costs: Continuous developments in genetic testing technology, such as targeted gene sequencing and whole exome sequencing, have made testing more accessible and cost-effective. This has enhanced the availability of genetic testing services and their use in the diagnosis of rare disorders.

What Are The Main Obstacles That The Global Rare Disease Genetic Testing Market Faces?

While genetic testing has gained traction in many industrialized countries, knowledge and accessibility remain limited in certain places. This can stymie the general adoption of rare illness genetic testing and cause persons with uncommon diseases to get delayed diagnosis and treatment. Furthermore, there are ethical and privacy problems associated with genetic testing: Genetic testing necessitates the collection and analysis of sensitive personal data. Concerns regarding privacy, data security, and potential discrimination based on genetic information can stymie widespread adoption of genetic testing for uncommon disorders.

What Market Development Prospects Are There For Rare Disease Genetic Testing Globally?

Expansion of genetic testing services in emerging markets: As healthcare infrastructure and awareness increase in emerging markets, there is a chance for genetic testing services for rare diseases to expand. This can lead to earlier detection and management of rare diseases in these areas. Collaborations between pharmaceutical corporations and genetic testing companies: Collaborations between pharmaceutical companies and genetic testing companies can help to accelerate the development of tailored medicines and precision medicine methods for rare diseases. Combining genetic testing data with medication development activities improves the potential for novel treatments.

Market Drivers

The global Rare Disease Genetic Testing Market is driven by several factors. The following are the key drivers of the global Rare Disease Genetic Testing Market:

Increasing Prevalence And Recognition Of Rare Diseases

The rising prevalence and awareness of uncommon diseases are major drivers in the healthcare business. Rare diseases, sometimes known as orphan diseases, are distinguished by their low population prevalence. There has been an increasing understanding and awareness of many illnesses over time, resulting in improved recognition and diagnosis.

Medical research and technology advancements have been critical in finding and comprehending rare diseases. Healthcare experts may now more reliably diagnose these disorders because to advances in genetic testing and molecular diagnostics, allowing for timely interventions and appropriate therapy.

Furthermore, the rise of patient advocacy groups and support networks has contributed to a greater awareness of uncommon diseases. These groups work relentlessly to raise awareness, support research, and lobby for better access to healthcare services for those suffering from rare diseases.

Market Restraints

The global Rare Disease Genetic Testing Market faces some challenges that may hinder its growth. These include the following:

Ethical And Privacy Concerns Related To Genetic Testing

Ethical and privacy concerns are significant restrictions in the Rare Disease Genetic Testing Market. When it comes to genetic testing, there are ethical problems such as informed consent, potential prejudice, and the use of sensitive genetic information. One important source of concern is the possible misuse or mishandling of genetic data. Genetic testing entails the collecting and analysis of personal genetic information, which presents privacy concerns. There is a potential that this information will be obtained or utilized unlawfully, resulting in discrimination in areas such as employment or insurance coverage.

Opportunities

The global Rare Disease Genetic Testing Market offers significant growth opportunities. These include the following:

Expansion Of Genetic Testing Services In Emerging Markets

The expansion of genetic testing services in emerging markets represents a substantial opportunity in the Rare Disease Genetic Testing Market. As these economies continue to develop and invest in healthcare infrastructure, there is an increasing demand for improved diagnostic technology and tailored treatment.

In emerging economies, there is frequently underdiagnosis and restricted access to genetic testing services for rare disorders. Expanding these services can help close this gap and offer individuals with better access to accurate diagnosis, suitable treatments, and better management of their disorders.

The availability of genetic testing services in emerging economies can also help to advance our understanding of rare diseases. Researchers can acquire insights into the genetic differences and incidence of uncommon diseases in these places by gathering data from varied populations. This understanding can lead to breakthroughs in treatment options and the creation of more effective targeted medicines for specific groups. Furthermore, the growth of genetic testing services in emerging economies has the potential to foster cooperation between local healthcare providers and foreign experts. This sharing of knowledge and skills has the potential to improve capacity, healthcare delivery, and, ultimately, patient outcomes.

Competitive Landscape

Rare Disease Genetic Testing Market Report

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Key Players

The global Rare Disease Genetic Testing Market is highly competitive, with several key players. Some of the major players in the market and their market share are as follows:

  • Quest Diagnostics, Inc
  • Centogene N.V.
  • Invitae Corp.
  • 3billion, Inc.
  • Arup Laboratories
  • Eurofins Scientific
  • Strand Life Sciences
  • Ambry Genetics
  • Perkin Elmer, Inc.
  • Macrogen, Inc.
  • Baylor Genetics
  • Color Genomics, Inc.
  • Health Network Laboratories
  • PreventionGenetics
  • Progenity, Inc.
  • Coopersurgical, Inc.
  • Fulgent Genetics Inc.
  • Myriad Genetics, Inc.
  • Laboratory Corporation Of America Holdings
  • Opko Health, Inc.
  • ArtemisDNA

These organizations prioritize product innovation, Disease Area expansion, and mergers and acquisitions to stay competitive.

The global Rare Disease Genetic Testing Market’s key players continually seek to stay ahead by offering new Next-Generation Sequencing (NGS)s and developments.

In December 2020, Cell ID Pte. Ltd., a Singapore-based manufacturer of genetic testing tools, will release the Quiz PCR Biochip, a portable COVID-19 genetic test. This is a portable, transportable genetic test kit the size of a palm that uses an app to assess whether or not a person has COVID-19. This device also included with a QR code for tracking. The device makes use of pooled screening technologies. This is easily transportable and may be used to conduct testing at any time.

In January 2022, Exact Sciences, a manufacturer of genetic testing instruments and a molecular diagnostics company based in the United States, paid $190 million for Prevention Genetics. As a result of this acquisition, Exact Sciences plans to expand hereditary cancer diagnostics for more people.

Summary of Key Findings

  • Service expansion for genetic testing in emerging markets
  • Market segmented by Next-Generation Sequencing (NGS), Targeted Genetic Testing,  Non-Invasive Prenatal Testing (NIPT), Carrier Screening, Diagnostic Testing, Preimplantation Genetic Testing (PGT), Direct-to-Consumer (DTC) Genetic Testing, Technological Platforms, Bioinformatics and Data Analysis, End-User and region
  • WES is currently the main category in this market
  • Panel Testing is the market demand governing segment.
  • North America is leading market growth; the market is highly competitive with key players including Quest Diagnostics, Inc.; Centogene N.V.; Invitae Corp.; 3billion, Inc.; Arup Laboratories

Future Outlook

  • Adoption of genetic testing for uncommon disorders is increasing.
  • Technological advancements in genetic sequencing
  • Raising awareness and comprehension of rare diseases
  • Increased availability of genetic counselling services
  • Incorporation of genetic testing into standard healthcare practices
  • Targeted therapy development based on genetic test results
  • Collaboration between academic institutions and genetic testing firms
  • Market expansion in emerging economies

Segmentation

  • By Next-Generation Sequencing (NGS):
    • Whole Genome Sequencing (WGS)
    • Whole Exome Sequencing (WES)
  • By Targeted Genetic Testing:
    • Panel Testing
    • Single Gene Testing
  • By Non-Invasive Prenatal Testing (NIPT):
    • Screening for Genetic Disorders in the Fetus
  • By Carrier Screening:
    • Identifying Carriers of Genetic Mutations
  • By Diagnostic Testing:
    • Confirmatory Testing
    • Comprehensive Diagnostic Testing
  • By Preimplantation Genetic Testing (PGT):
    • Screening Embryos for Genetic Abnormalities
  • By Direct-to-Consumer (DTC) Genetic Testing:
    • Consumer-Initiated Genetic Testing Services
  • By Technological Platforms:
    • Microarray Technology
    • PCR (Polymerase Chain Reaction)
  • By Bioinformatics and Data Analysis:
    • Interpretation Services
    • Data Storage and Management
  • By Bioinformatics and Data Analysis:
    • Hospitals and Clinics
    • Genetic Testing Laboratories
    • Direct-to-Consumer Companies
  • By Region
    • North America
      • The U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • The U.K.
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • South-east Asia
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Argentina
      • Rest of Latin America
    • Middle East & Africa
      • GCC Countries
      • South Africa
      • Rest of Middle East and Africa
Table of Content
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Market Introduction
2. Executive Summary
2.1. Market Snapshot: Global  Rare Disease Genetic Testing Market
2.1.1. Global  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS
2.1.2. Global  Rare Disease Genetic Testing Market, By Targeted Genetic Testing
2.1.3. Global  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT)
2.1.4. Global  Rare Disease Genetic Testing Market, By Carrier Screening
2.1.5. Global  Rare Disease Genetic Testing Market, By Diagnostic Testing
2.1.6. Global  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT)
2.1.7. Global  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing
2.1.8. Global  Rare Disease Genetic Testing Market, By Technological Platforms
2.1.9. Global  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis
2.1.10. Global  Rare Disease Genetic Testing Market, By End-User
2.1.11. Global  Rare Disease Genetic Testing Market, By Region
2.2. Insights from Primary Respondents
3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global  Rare Disease Genetic Testing Market Value, 2017-2030, (US$ Mn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Rare Disease Genetic Testing Market Drivers
3.2.2. Rare Disease Genetic Testing Market Restraints
3.2.3. Rare Disease Genetic Testing Market Opportunities
3.2.4. Major  Rare Disease Genetic Testing Market Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Next-Generation Sequencing (NGS
3.5.2. Targeted Genetic Testing
3.5.3. Non-Invasive Prenatal Testing (NIPT)
3.5.4. Carrier Screening
3.5.5. Diagnostic Testing
3.5.6. Geography
4. Market Competitive Landscape Analysis
4.1. Company Market Share Analysis, 2022
4.1.1. Global  Rare Disease Genetic Testing Market: Company Market Share, Value 2022
4.1.2. Global  Rare Disease Genetic Testing Market: Top 6 Company Market Share, Value 2022
4.1.3. Global  Rare Disease Genetic Testing Market: Top 3 Company Market Share, Value 2022
4.2. Global  Rare Disease Genetic Testing Market: Company Revenue Share Analysis, 2022
4.3. Company Assessment Metrics, 2022
4.3.1. Stars
4.3.2. Emerging Leaders
4.3.3. Pervasive Players
4.3.4. Participants
4.4. Startups/ SMEs Assessment Metrics, 2022
4.4.1. Progressive Companies
4.4.2. Responsive Companies
4.4.3. Dynamic Companies
4.4.4. Starting Blocks
4.5. Strategic Development
4.5.1. Acquisition and Mergers
4.5.2. New Type Launch
4.5.3. Regional Expansion
4.5.4. Partnerships
4.6. Key Player Type Matrix
4.7. Potential for New Players in the Global  Rare Disease Genetic Testing Market
5. Premium Insights
5.1. STAR (Situation, Task, Action, Results) Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Bargaining Power of Buyers/Consumers
5.2.3. Bargaining Power of Suppliers
5.2.4. Threat of Substitute Types
5.2.5. Intensity of Competitive Rivalry
5.3. PESTEL Analysis
5.3.1. Political Factors
5.3.2. Economic Factors
5.3.3. Social Factors
5.3.4. Technological Factors
5.3.5. Environmental Factors
5.3.6. Legal Factors
5.4. Key Market Trends
5.4.1. Demand Side Trends
5.4.2. Supply Side Trends
5.5. Value Chain Analysis
5.6. Technology Analysis
5.6.1. Plasma Protein Binding Studies in the global market
5.6.2. Patent Analysis
5.6.3. Emerging technologies and their potential disruption to the market
5.7. Consumer Behaviour Analysis
5.7.1. Consumer Preferences and Expectations
5.7.2. Factors Influencing Consumer Buying Decisions
5.7.2.1. North America
5.7.2.2. Europe
5.7.2.3. Asia Pacific
5.7.2.4. Latin America
5.7.2.5. Middle East and Africa
5.7.3. Consumer Pain Points
5.8. Analysis and Recommendations
5.9. Adjacent Market Analysis
6. Market Positioning of Key Players, 2022
6.1. Company market share of key players, 2022
6.2. Competitive Benchmarking
6.3. Market Positioning of Key Vendors
6.4. Geographical Presence Analysis
6.5. Major Strategies Adopted by Key Players
6.5.1. Key Strategies Analysis
6.5.2. Mergers and Acquisitions
6.5.3. Partnerships
6.5.4. Type Launch
6.5.5. Geographical Expansion
6.5.6. Autoimmune Diseases
7. Impact Analysis of COVID 19 and Russia – Ukraine War on  Rare Disease Genetic Testing Market
7.1. Ukraine-Russia War Impact
7.1.1. Uncertainty and Economic Instability
7.1.2. Supply chain disruptions
7.1.3. Regional market shifts
7.1.4. Shift in government priorities
7.2. COVID-19 Impact Analysis
7.2.1. Supply Chain Disruptions
7.2.2. Demand Fluctuations
7.2.3. Shift in Type Mix
7.2.4. Reduced Plasma Protein Binding Studies Activity
7.2.5. Regional Impact Analysis
7.2.5.1. North America
7.2.5.2. Europe
7.2.5.3. Asia Pacific
7.2.5.4. Latin America
7.2.5.5. Middle East and Africa
8. Global  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS
8.1. Global  Rare Disease Genetic Testing Market Overview, By Next-Generation Sequencing (NGS
8.1.1. Global  Rare Disease Genetic Testing Market Revenue Share, By Next-Generation Sequencing (NGS, 2022 Vs 2030 (in %)
8.2. Whole Genome Sequencing (WGS)
8.2.1. Global  Rare Disease Genetic Testing Market, By WHOLE GENOME SEQUENCING (WGS), By Region, 2017-2030 (US$ Mn)
8.2.2. Market Dynamics for WHOLE GENOME SEQUENCING (WGS)
8.2.2.1. Drivers
8.2.2.2. Restraints
8.2.2.3. Opportunities
8.2.2.4. Trends
8.3. Whole Exome Sequencing (WES)
8.3.1. Global  Rare Disease Genetic Testing Market, By Whole Exome Sequencing (WES), By Region, 2017-2030 (US$ Mn)
8.3.2. Market Dynamics for Whole Exome Sequencing (WES)
8.3.2.1. Drivers
8.3.2.2. Restraints
8.3.2.3. Opportunities
8.3.2.4. Trends
9. Global  Rare Disease Genetic Testing Market, By Targeted Genetic Testing
9.1. Global  Rare Disease Genetic Testing Market Overview, By Targeted Genetic Testing
9.1.1. Global  Rare Disease Genetic Testing Market Revenue Share, By Targeted Genetic Testing, 2022 Vs 2030 (in %)
9.2. Panel Testing
9.2.1. Global  Rare Disease Genetic Testing Market, By Panel Testing, By Region, 2017-2030 (US$ Mn)
9.2.2. Market Dynamics for Panel Testing
9.2.2.1. Drivers
9.2.2.2. Restraints
9.2.2.3. Opportunities
9.2.2.4. Trends
9.3. Single Gene Testing
9.3.1. Global  Rare Disease Genetic Testing Market, By Single Gene Testing, By Region, 2017-2030 (US$ Mn)
9.3.2. Market Dynamics for Single Gene Testing
9.3.2.1. Drivers
9.3.2.2. Restraints
9.3.2.3. Opportunities
9.3.2.4. Trends
10. Global  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT)
10.1. Global  Rare Disease Genetic Testing Market Overview, By Non-Invasive Prenatal Testing (NIPT)
10.1.1. Global  Rare Disease Genetic Testing Market Revenue Share, By Non-Invasive Prenatal Testing (NIPT), 2022 Vs 2030 (in %)
10.2. Screening for Genetic Disorders in the Fetus
10.2.1. Global  Rare Disease Genetic Testing Market, By Screening for Genetic Disorders in the Fetus, By Region, 2017-2030 (US$ Mn)
10.2.2. Market Dynamics for Screening for Genetic Disorders in the Fetus
10.2.2.1. Drivers
10.2.2.2. Restraints
10.2.2.3. Opportunities
10.2.2.4. Trends
11. Global  Rare Disease Genetic Testing Market, By Carrier Screening
11.1. Global  Rare Disease Genetic Testing Market Overview, by Carrier Screening
11.1.1. Global  Rare Disease Genetic Testing Market Revenue Share, By Carrier Screening, 2022 Vs 2030 (in %)
11.2. Identifying Carriers of Genetic Mutations
11.2.1. Global  Rare Disease Genetic Testing Market, By Identifying Carriers of Genetic Mutations, By Region, 2017-2030 (US$ Mn)
11.2.2. Market Dynamics for Identifying Carriers of Genetic Mutations
11.2.2.1. Drivers
11.2.2.2. Restraints
11.2.2.3. Opportunities
11.2.2.4. Trends
12. Global  Rare Disease Genetic Testing Market, By Diagnostic Testing
12.1. Global  Rare Disease Genetic Testing Market Overview, By Diagnostic Testing
12.1.1. Global  Rare Disease Genetic Testing Market Revenue Share, By Diagnostic Testing, 2022 Vs 2030 (in %)
12.2. Confirmatory Testing
12.2.1. Global  Rare Disease Genetic Testing Market, By Confirmatory Testing, By Region, 2017-2030 (US$ Mn)
12.2.2. Market Dynamics for Confirmatory Testing
12.2.2.1. Drivers
12.2.2.2. Restraints
12.2.2.3. Opportunities
12.2.2.4. Trends
12.3. Comprehensive Diagnostic Testing
12.3.1. Global  Rare Disease Genetic Testing Market, By Comprehensive Diagnostic Testing, By Region, 2017-2030 (US$ Mn)
12.3.2. Market Dynamics for Comprehensive Diagnostic Testing
12.3.2.1. Drivers
12.3.2.2. Restraints
12.3.2.3. Opportunities
12.3.2.4. Trends
13. Global  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT)
13.1. Global  Rare Disease Genetic Testing Market Overview, By Preimplantation Genetic Testing (PGT)
13.1.1. Global  Rare Disease Genetic Testing Market Revenue Share, By Preimplantation Genetic Testing (PGT), 2022 Vs 2030 (in %)
13.2. Screening Embryos for Genetic Abnormalities
13.2.1. Global  Rare Disease Genetic Testing Market, By Screening Embryos for Genetic Abnormalities, By Region, 2017-2030 (US$ Mn)
13.2.2. Market Dynamics for Screening Embryos for Genetic Abnormalities
13.2.2.1. Drivers
13.2.2.2. Restraints
13.2.2.3. Opportunities
13.2.2.4. Trends
14. Global  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing
14.1. Global  Rare Disease Genetic Testing Market Overview, By Direct-to-Consumer (DTC) Genetic Testing
14.1.1. Global  Rare Disease Genetic Testing Market Revenue Share, By Direct-to-Consumer (DTC) Genetic Testing, 2022 Vs 2030 (in %)
14.2. Consumer-Initiated Genetic Testing Services
14.2.1. Global  Rare Disease Genetic Testing Market, By Consumer-Initiated Genetic Testing Services, By Region, 2017-2030 (US$ Mn)
14.2.2. Market Dynamics for Consumer-Initiated Genetic Testing Services
14.2.2.1. Drivers
14.2.2.2. Restraints
14.2.2.3. Opportunities
14.2.2.4. Trends
15. Global  Rare Disease Genetic Testing Market, By Technological Platforms
15.1. Global  Rare Disease Genetic Testing Market Overview, By Technological Platforms
15.1.1. Global  Rare Disease Genetic Testing Market Revenue Share, By Technological Platforms, 2022 Vs 2030 (in %)
15.2. Microarray Technology
15.2.1. Global  Rare Disease Genetic Testing Market, By Microarray Technology, By Region, 2017-2030 (US$ Mn)
15.2.2. Market Dynamics for Microarray Technology
15.2.2.1. Drivers
15.2.2.2. Restraints
15.2.2.3. Opportunities
15.2.2.4. Trends
15.3. Microarray PCR (Polymerase Chain Reaction)
15.3.1. Global  Rare Disease Genetic Testing Market, By Microarray PCR (Polymerase Chain Reaction), By Region, 2017-2030 (US$ Mn)
15.3.2. Market Dynamics for Microarray PCR (Polymerase Chain Reaction)
15.3.2.1. Drivers
15.3.2.2. Restraints
15.3.2.3. Opportunities
15.3.2.4. Trends
16. Global  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis
16.1. Global  Rare Disease Genetic Testing Market Overview, By Bioinformatics and Data Analysis
16.1.1. Global  Rare Disease Genetic Testing Market Revenue Share, By Bioinformatics and Data Analysis, 2022 Vs 2030 (in %)
16.2. Interpretation Services
16.2.1. Global  Rare Disease Genetic Testing Market, By Interpretation Services, By Region, 2017-2030 (US$ Mn)
16.2.2. Market Dynamics for Interpretation Services
16.2.2.1. Drivers
16.2.2.2. Restraints
16.2.2.3. Opportunities
16.2.2.4. Trends
16.3. Data Storage and Management
16.3.1. Global  Rare Disease Genetic Testing Market, By Data Storage and Management, By Region, 2017-2030 (US$ Mn)
16.3.2. Market Dynamics for Data Storage and Management
16.3.2.1. Drivers
16.3.2.2. Restraints
16.3.2.3. Opportunities
16.3.2.4. Trends
17. Global  Rare Disease Genetic Testing Market, By End-User
17.1. Global  Rare Disease Genetic Testing Market Overview, By End-User
17.1.1. Global  Rare Disease Genetic Testing Market Revenue Share, By End-User, 2022 Vs 2030 (in %)
17.2. Hospitals and Clinics
17.2.1. Global  Rare Disease Genetic Testing Market, By Hospitals and Clinics, By Region, 2017-2030 (US$ Mn)
17.2.2. Market Dynamics for Hospitals and Clinics
17.2.2.1. Drivers
17.2.2.2. Restraints
17.2.2.3. Opportunities
17.2.2.4. Trends
17.3. Genetic Testing Laboratories
17.3.1. Global  Rare Disease Genetic Testing Market, By Genetic Testing Laboratories, By Region, 2017-2030 (US$ Mn)
17.3.2. Market Dynamics for Genetic Testing Laboratories
17.3.2.1. Drivers
17.3.2.2. Restraints
17.3.2.3. Opportunities
17.3.2.4. Trends
17.4. Direct-to-Consumer Companies
17.4.1. Global  Rare Disease Genetic Testing Market, By Direct-to-Consumer Companies, By Region, 2017-2030 (US$ Mn)
17.4.2. Market Dynamics for Direct-to-Consumer Companies
17.4.2.1. Drivers
17.4.2.2. Restraints
17.4.2.3. Opportunities
17.4.2.4. Trends
18. Global  Rare Disease Genetic Testing Market, By Region
18.1. Global  Rare Disease Genetic Testing Market Overview, by Region
18.1.1. Global  Rare Disease Genetic Testing Market, By Region, 2022 vs 2030 (in%)
18.2. Next-Generation Sequencing (NGS
18.2.1. Global  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2030 (US$ Mn)
18.3. Targeted Genetic Testing
18.3.1. Global  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2030 (US$ Mn)
18.4. Non-Invasive Prenatal Testing (NIPT)
18.4.1. Global  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2030 (US$ Mn)
18.5. Carrier Screening
18.5.1. Global  Rare Disease Genetic Testing Market, By Carrier Screening, 2017-2030 (US$ Mn)
18.6. Diagnostic Testing
18.6.1. Global  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2030 (US$ Mn)
18.7. Preimplantation Genetic Testing (PGT)
18.7.1. Global  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2030 (US$ Mn)
18.8. Direct-to-Consumer (DTC) Genetic Testing
18.8.1. Global  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2030 (US$ Mn)
18.9. Technological Platforms
18.9.1. Global  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2030 (US$ Mn)
18.10. Bioinformatics and Data Analysis
18.10.1. Global  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, 2017-2030 (US$ Mn)
18.11. End-User
18.11.1. Global  Rare Disease Genetic Testing Market, By End-User, 2017-2030 (US$ Mn)
19. North America  Rare Disease Genetic Testing Market Analysis
19.1. Overview
19.1.1. Market Dynamics for North America
19.1.1.1. Drivers
19.1.1.2. Restraints
19.1.1.3. Opportunities
19.1.1.4. Trends
19.2. North America  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2030(US$ Mn)
19.2.1. Overview
19.2.2. SRC Analysis
19.3. North America  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2030(US$ Mn)
19.3.1. Overview
19.3.2. SRC Analysis
19.4. North America  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2030(US$ Mn)
19.4.1. Overview
19.4.2. SRC Analysis
19.5. North America  Rare Disease Genetic Testing Market, By Carrier Screening, 2017-2030(US$ Mn)
19.5.1. Overview
19.5.2. SRC Analysis
19.6. North America  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2030(US$ Mn)
19.6.1. Overview
19.6.2. SRC Analysis
19.7. North America  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2030(US$ Mn)
19.7.1. Overview
19.7.2. SRC Analysis
19.8. North America  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2030(US$ Mn)
19.8.1. Overview
19.8.2. SRC Analysis
19.9. North America  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2030(US$ Mn)
19.9.1. Overview
19.9.2. SRC Analysis
19.10. North America  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, 2017-2030(US$ Mn)
19.10.1. Overview
19.10.2. SRC Analysis
19.11. North America  Rare Disease Genetic Testing Market, By End-User, 2017-2030(US$ Mn)
19.11.1. Overview
19.11.2. SRC Analysis
19.12. North America  Rare Disease Genetic Testing Market, by Country, 2017-2030(US$ Mn)
19.12.1. North America  Rare Disease Genetic Testing Market, by Country, 2022 Vs 2030 (in%)
19.12.2. U.S.
19.12.3. Canada
19.12.4. Mexico
20. Europe  Rare Disease Genetic Testing Market Analysis
20.1. Overview
20.1.1. Market Dynamics for North America
20.1.1.1. Drivers
20.1.1.2. Restraints
20.1.1.3. Opportunities
20.1.1.4. Trends
20.2. Europe  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2030(US$ Mn)
20.2.1. Overview
20.2.2. SRC Analysis
20.3. Europe  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2030(US$ Mn)
20.3.1. Overview
20.3.2. SRC Analysis
20.4. Europe  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2030(US$ Mn)
20.4.1. Overview
20.4.2. SRC Analysis
20.5. Europe  Rare Disease Genetic Testing Market, By Carrier Screening, 2017-2030(US$ Mn)
20.5.1. Overview
20.5.2. SRC Analysis
20.6. Europe  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2030(US$ Mn)
20.6.1. Overview
20.6.2. SRC Analysis
20.7. Europe  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2030(US$ Mn)
20.7.1. Overview
20.7.2. SRC Analysis
20.8. Europe  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2030(US$ Mn)
20.8.1. Overview
20.8.2. SRC Analysis
20.9. Europe  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2030(US$ Mn)
20.9.1. Overview
20.9.2. SRC Analysis
20.10. Europe  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, 2017-2030(US$ Mn)
20.10.1. Overview
20.10.2. SRC Analysis
20.11. Europe  Rare Disease Genetic Testing Market, By End-User, 2017-2030(US$ Mn)
20.11.1. Overview
20.11.2. SRC Analysis
20.12. Europe  Rare Disease Genetic Testing Market, by Country, 2017-2030 (US$ Mn)
20.12.1. Europe  Rare Disease Genetic Testing Market, by Country, 2022 Vs 2030 (in%)
20.12.2. UK
20.12.3. France
20.12.4. Germany
20.12.5. Italy
20.12.6. Spain
20.12.7. Benelux
20.12.8. Russia
20.12.9. Rest of Europe
21. Asia Pacific  Rare Disease Genetic Testing Market Analysis
21.1. Overview
21.1.1. Market Dynamics for North America
21.1.1.1. Drivers
21.1.1.2. Restraints
21.1.1.3. Opportunities
21.1.1.4. Trends
21.2. Asia Pacific  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2030(US$ Mn)
21.2.1. Overview
21.2.2. SRC Analysis
21.3. Asia Pacific  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2030(US$ Mn)
21.3.1. Overview
21.3.2. SRC Analysis
21.4. Asia Pacific  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2030(US$ Mn)
21.4.1. Overview
21.4.2. SRC Analysis
21.5. Asia Pacific  Rare Disease Genetic Testing Market, By Carrier Screening, 2017-2030(US$ Mn)
21.5.1. Overview
21.5.2. SRC Analysis
21.6. Asia Pacific  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2030(US$ Mn)
21.6.1. Overview
21.6.2. SRC Analysis
21.7. Asia Pacific  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2030(US$ Mn)
21.7.1. Overview
21.7.2. SRC Analysis
21.8. Asia Pacific  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2030(US$ Mn)
21.8.1. Overview
21.8.2. SRC Analysis
21.9. Asia Pacific  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2030(US$ Mn)
21.9.1. Overview
21.9.2. SRC Analysis
21.10. Asia Pacific  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, 2017-2030(US$ Mn)
21.10.1. Overview
21.10.2. SRC Analysis
21.11. Asia Pacific  Rare Disease Genetic Testing Market, By End-User, 2017-2030(US$ Mn)
21.11.1. Overview
21.11.2. SRC Analysis
21.12. Asia Pacific  Rare Disease Genetic Testing Market, by Country, 2017-2030 (US$ Mn)
21.12.1. Asia Pacific  Rare Disease Genetic Testing Market, by Country, 2022 Vs 2030 (in%)
21.12.2. China
21.12.3. Japan
21.12.4. India
21.12.5. South Korea
21.12.6. South East Asia
21.12.7. Rest of Asia Pacific
22. Latin America  Rare Disease Genetic Testing Market Analysis
22.1. Overview
22.1.1. Market Dynamics for North America
22.1.1.1. Drivers
22.1.1.2. Restraints
22.1.1.3. Opportunities
22.1.1.4. Trends
22.2. Latin America  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2030(US$ Mn)
22.2.1. Overview
22.2.2. SRC Analysis
22.3. Latin America  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2030(US$ Mn)
22.3.1. Overview
22.3.2. SRC Analysis
22.4. Latin America  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2030(US$ Mn)
22.4.1. Overview
22.4.2. SRC Analysis
22.5. Latin America  Rare Disease Genetic Testing Market, By Carrier Screening, 2017-2030(US$ Mn)
22.5.1. Overview
22.5.2. SRC Analysis
22.6. Latin America  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2030(US$ Mn)
22.6.1. Overview
22.6.2. SRC Analysis
22.7. Latin America  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2030(US$ Mn)
22.7.1. Overview
22.7.2. SRC Analysis
22.8. Latin America  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2030(US$ Mn)
22.8.1. Overview
22.8.2. SRC Analysis
22.9. Latin America  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2030(US$ Mn)
22.9.1. Overview
22.9.2. SRC Analysis
22.10. Latin America  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, 2017-2030(US$ Mn)
22.10.1. Overview
22.10.2. SRC Analysis
22.11. Latin America  Rare Disease Genetic Testing Market, By End-User, 2017-2030(US$ Mn)
22.11.1. Overview
22.11.2. SRC Analysis
22.12. Latin America  Rare Disease Genetic Testing Market, by Country, 2017-2030 (US$ Mn)
22.12.1. Latin America  Rare Disease Genetic Testing Market, by Country, 2022 Vs 2030 (in%)
22.12.2. Brazil
22.12.3. Argentina
22.12.4. Rest of Latin America
23. Middle East  Rare Disease Genetic Testing Market Analysis
23.1. Overview
23.1.1. Market Dynamics for North America
23.1.1.1. Drivers
23.1.1.2. Restraints
23.1.1.3. Opportunities
23.1.1.4. Trends
23.2. Middle East  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2030(US$ Mn)
23.2.1. Overview
23.2.2. SRC Analysis
23.3. Middle East  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2030(US$ Mn)
23.3.1. Overview
23.3.2. SRC Analysis
23.4. Middle East  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2030(US$ Mn)
23.4.1. Overview
23.4.2. SRC Analysis
23.5. Middle East  Rare Disease Genetic Testing Market, By Carrier Screening, 2017-2030(US$ Mn)
23.5.1. Overview
23.5.2. SRC Analysis
23.6. Middle East  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2030(US$ Mn)
23.6.1. Overview
23.6.2. SRC Analysis
23.7. Middle East  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2030(US$ Mn)
23.7.1. Overview
23.7.2. SRC Analysis
23.8. Middle East  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2030(US$ Mn)
23.8.1. Overview
23.8.2. SRC Analysis
23.9. Middle East  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2030(US$ Mn)
23.9.1. Overview
23.9.2. SRC Analysis
23.10. Middle East  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, 2017-2030(US$ Mn)
23.10.1. Overview
23.10.2. SRC Analysis
23.11. Middle East  Rare Disease Genetic Testing Market, By End-User, 2017-2030(US$ Mn)
23.11.1. Overview
23.11.2. SRC Analysis
23.12. Middle East  Rare Disease Genetic Testing Market, by Country, 2017-2030 (US$ Mn)
23.12.1. Middle East  Rare Disease Genetic Testing Market, by Country, 2022 Vs 2030 (in%)
23.12.2. UAE
23.12.3. Saudi Arabia
23.12.4. Rest of Middle East
24. Africa  Rare Disease Genetic Testing Market Analysis
24.1. Overview
24.1.1. Market Dynamics for North America
24.1.1.1. Drivers
24.1.1.2. Restraints
24.1.1.3. Opportunities
24.1.1.4. Trends
24.2. Africa  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2030(US$ Mn)
24.2.1. Overview
24.2.2. SRC Analysis
24.3. Africa  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2030(US$ Mn)
24.3.1. Overview
24.3.2. SRC Analysis
24.4. Africa  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2030(US$ Mn)
24.4.1. Overview
24.4.2. SRC Analysis
24.5. Africa  Rare Disease Genetic Testing Market, By Carrier Screening, 2017-2030(US$ Mn)
24.5.1. Overview
24.5.2. SRC Analysis
24.6. Africa  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2030(US$ Mn)
24.6.1. Overview
24.6.2. SRC Analysis
24.7. Africa  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2030(US$ Mn)
24.7.1. Overview
24.7.2. SRC Analysis
24.8. Africa  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2030(US$ Mn)
24.8.1. Overview
24.8.2. SRC Analysis
24.9. Africa  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2030(US$ Mn)
24.9.1. Overview
24.9.2. SRC Analysis
24.10. Africa  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, 2017-2030(US$ Mn)
24.10.1. Overview
24.10.2. SRC Analysis
24.11. Africa  Rare Disease Genetic Testing Market, By End-User, 2017-2030(US$ Mn)
24.11.1. Overview
24.11.2. SRC Analysis
24.12. Africa  Rare Disease Genetic Testing Market, by Country, 2017-2030 (US$ Mn)
24.12.1. Middle East  Rare Disease Genetic Testing Market, by Country, 2022 Vs 2030 (in%)
24.12.2. South Africa
24.12.3. Egypt
24.12.4. Rest of Africa
25. Company Profiles
25.1. Quest Diagnostics, Inc.
25.1.1. Company Overview
25.1.2. Types/Services Portfolio
25.1.3. Geographical Presence
25.1.4. SWOT Analysis
25.1.5. Financial Summary
25.1.5.1. Market Revenue and Net Profit (2019-2022)
25.1.5.2. Business Segment Revenue Analysis
25.1.5.3. Geographical Revenue Analysis
25.2. Centogene N.V.
25.3. Invitae Corp.
25.4. 3billion, Inc.
25.5. Arup Laboratories
25.6. Eurofins Scientific
25.7. Strand Life Sciences
25.8. Ambry Genetics
25.9. Perkin Elmer, Inc.
25.10. Macrogen, Inc.
25.11. Baylor Genetics
25.12. Color Genomics, Inc.
25.13. Health Network Laboratories
25.14. PreventionGenetics
25.15. Progenity, Inc.
25.16. Coopersurgical, Inc.
25.17. Fulgent Genetics Inc.
25.18. Myriad Genetics, Inc.
25.19. Laboratory Corporation Of America Holdings
25.20. Opko Health, Inc.
25.21. Artemis DNA
26. Research Methodology
26.1. Research Methodology
26.2. Screening for Genetic Disorders in the Fetus – Secondary Research
26.3. Screening for Genetic Disorders in the FetusI – Data Modelling
26.3.1. Company Share Analysis Model
26.3.2. Revenue Based Modelling
26.4. Screening for Genetic Disorders in the FetusII – Primary Research
26.5. Research Limitations
26.5.1. Assumptions
List of Figures
FIG. 1 Global  Rare Disease Genetic Testing Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global  Rare Disease Genetic Testing Market Segmentation
FIG. 4 Global  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2022 (US$ Mn)
FIG. 5 Global  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2022 (US$ Mn)
FIG. 6 Global  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2022 (US$ Mn)
FIG. 7 Global  Rare Disease Genetic Testing Market, by Carrier Screening, 2022 (US$ Mn)
FIG. 8 Global  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2022 (US$ Mn)
FIG. 9 Global  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2022 (US$ Mn)
FIG. 10 Global  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2022 (US$ Mn)
FIG. 11 Global  Rare Disease Genetic Testing Market, By Technological Platforms, 2022 (US$ Mn)
FIG. 12 Global  Rare Disease Genetic Testing Market, by Bioinformatics and Data Analysis, 2022 (US$ Mn)
FIG. 13 Global  Rare Disease Genetic Testing Market, By End-User, 2022 (US$ Mn)
FIG. 14 Global  Rare Disease Genetic Testing Market, by Geography, 2022 (US$ Mn)
FIG. 15 Attractive Investment Proposition, By Next-Generation Sequencing (NGS, 2022
FIG. 16 Attractive Investment Proposition, By Targeted Genetic Testing, 2022
FIG. 17 Attractive Investment Proposition, By Non-Invasive Prenatal Testing (NIPT), 2022
FIG. 18 Attractive Investment Proposition, By Carrier Screening, 2022
FIG. 19 Attractive Investment Proposition, By Diagnostic Testing, 2022
FIG. 20 Attractive Investment Proposition, By Preimplantation Genetic Testing (PGT), 2022
FIG. 21 Attractive Investment Proposition, By Direct-to-Consumer (DTC) Genetic Testing, 2022
FIG. 22 Attractive Investment Proposition, By Technological Platforms, 2022
FIG. 23 Attractive Investment Proposition, By Bioinformatics and Data Analysis, 2022
FIG. 24 Attractive Investment Proposition, By End-User, 2022
FIG. 25 Attractive Investment Proposition, by Geography, 2022
FIG. 26 Global Market Share Analysis of Key  Rare Disease Genetic Testing Market Manufacturers, 2022
FIG. 27 Global Market Positioning of Key  Rare Disease Genetic Testing Market Manufacturers, 2022
FIG. 28 Global  Rare Disease Genetic Testing Market Value Contribution, By Next-Generation Sequencing (NGS, 2022 & 2030 (Value %)
FIG. 29 Global  Rare Disease Genetic Testing Market, by WHOLE GENOME SEQUENCING (WGS), Value, 2017-2030 (US$ Mn)
FIG. 30 Global  Rare Disease Genetic Testing Market, by Whole Exome Sequencing (WES), Value, 2017-2030 (US$ Mn)
FIG. 31 Global  Rare Disease Genetic Testing Market Value Contribution, By Targeted Genetic Testing, 2022 & 2030 (Value %)
FIG. 32 Global  Rare Disease Genetic Testing Market, by Panel Testing, Value, 2017-2030 (US$ Mn)
FIG. 33 Global  Rare Disease Genetic Testing Market, by Single Gene Testing, Value, 2017-2030 (US$ Mn)
FIG. 34 Global  Rare Disease Genetic Testing Market Value Contribution, By Non-Invasive Prenatal Testing (NIPT), 2022 & 2030 (Value %)
FIG. 35 Global  Rare Disease Genetic Testing Market, by Screening for Genetic Disorders in the Fetus, Value, 2017-2030 (US$ Mn)
FIG. 36 Global  Rare Disease Genetic Testing Market Value Contribution, By Carrier Screening, 2022 & 2030 (Value %)
FIG. 37 Global  Rare Disease Genetic Testing Market, by Identifying Carriers of Genetic Mutations, Value, 2017-2030 (US$ Mn)
FIG. 38 Global  Rare Disease Genetic Testing Market Value Contribution, By Diagnostic Testing, 2022 & 2030 (Value %)
FIG. 39 Global  Rare Disease Genetic Testing Market, by Confirmatory Testing, Value, 2017-2030 (US$ Mn)
FIG. 40 Global  Rare Disease Genetic Testing Market, by Comprehensive Diagnostic Testing, Value, 2017-2030 (US$ Mn)
FIG. 41 Global  Rare Disease Genetic Testing Market Value Contribution, By Preimplantation Genetic Testing (PGT), 2022 & 2030 (Value %)
FIG. 42 Global  Rare Disease Genetic Testing Market, by Screening Embryos for Genetic Abnormalities, Value, 2017-2030 (US$ Mn)
FIG. 43 Global  Rare Disease Genetic Testing Market Value Contribution, By Direct-to-Consumer (DTC) Genetic Testing, 2022 & 2030 (Value %)
FIG. 44 Global  Rare Disease Genetic Testing Market, by Consumer-Initiated Genetic Testing Services, Value, 2017-2030 (US$ Mn)
FIG. 45 Global  Rare Disease Genetic Testing Market Value Contribution, By Technological Platforms, 2022 & 2030 (Value %)
FIG. 46 Global  Rare Disease Genetic Testing Market, by Microarray Technology, Value, 2017-2030 (US$ Mn)
FIG. 47 Global  Rare Disease Genetic Testing Market, by Microarray PCR (Polymerase Chain Reaction), Value, 2017-2030 (US$ Mn)
FIG. 48 Global  Rare Disease Genetic Testing Market Value Contribution, By Bioinformatics and Data Analysis, 2022 & 2030 (Value %)
FIG. 49 Global  Rare Disease Genetic Testing Market, by Interpretation Services, Value, 2017-2030 (US$ Mn)
FIG. 50 Global  Rare Disease Genetic Testing Market, by Data Storage and Management, Value, 2017-2030 (US$ Mn)
FIG. 51 Global  Rare Disease Genetic Testing Market Value Contribution, By End-User, 2022 & 2030 (Value %)
FIG. 52 Global  Rare Disease Genetic Testing Market, by Hospitals and Clinics, Value, 2017-2030 (US$ Mn)
FIG. 53 Global  Rare Disease Genetic Testing Market, by Genetic Testing Laboratories, Value, 2017-2030 (US$ Mn)
FIG. 54 Global  Rare Disease Genetic Testing Market, by Direct-to-Consumer Companies, Value, 2017-2030 (US$ Mn)
FIG. 55 Global  Rare Disease Genetic Testing Market, by Industry and Academic Collaborations, Value, 2017-2030 (US$ Mn)
FIG. 56 North America  Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 57 U.S.  Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 58 Canada  Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 59 Mexico Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 60 Europe  Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 61 Germany  Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 62 France  Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 63 U.K.  Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 64 Italy  Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 65 Spain  Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 66 Benelux Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 67 Russia Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 68 Rest of Europe  Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 69 Asia Pacific  Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 70 China  Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 71 Japan  Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 72 India  Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 73 South Korea  Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 74 South-East Asia  Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 75 Rest of Asia Pacific  Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 76 Latin America  Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 77 Brazil  Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 78 Argentina Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 79 Rest of Latin America  Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 80 Middle East  Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 81 UAE Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 82 Saudi Arabia Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 83 Rest of Middle East  Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 84 Africa Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 85 South Africa  Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 86 Egypt Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 87 Rest of Africa  Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
List of Tables
TABLE 1 Market Snapshot: Global  Rare Disease Genetic Testing Market
TABLE 2 Global  Rare Disease Genetic Testing Market: Drivers Impact Analysis
TABLE 3 Global  Rare Disease Genetic Testing Market: Market Restraints Impact Analysis
TABLE 4 Global  Rare Disease Genetic Testing Market, by Competitive Benchmarking, 2022
TABLE 5 Global  Rare Disease Genetic Testing Market, by Geographical Presence Analysis, 2022
TABLE 6 Global  Rare Disease Genetic Testing Market, by Key Strategies Analysis, 2022
TABLE 7 Global  Rare Disease Genetic Testing Market, by Whole Genome Sequencing (WGS), By Region, 2017-2022 (US$ Mn)
TABLE 8 Global  Rare Disease Genetic Testing Market, by Whole Genome Sequencing (WGS), By Region, 2023-2030 (US$ Mn)
TABLE 9 Global  Rare Disease Genetic Testing Market, by Whole Exome Sequencing (WES), By Region, 2017-2022 (US$ Mn)
TABLE 10 Global  Rare Disease Genetic Testing Market, by Whole Exome Sequencing (WES), By Region, 2023-2030 (US$ Mn)
TABLE 11 Global  Rare Disease Genetic Testing Market, by Panel Testing, By Region, 2017-2022 (US$ Mn)
TABLE 12 Global  Rare Disease Genetic Testing Market, by Panel Testing, By Region, 2023-2030 (US$ Mn)
TABLE 13 Global  Rare Disease Genetic Testing Market, by Single Gene Testing, By Region, 2017-2022 (US$ Mn)
TABLE 14 Global  Rare Disease Genetic Testing Market, by Single Gene Testing, By Region, 2023-2030 (US$ Mn)
TABLE 15 Global  Rare Disease Genetic Testing Market, by Screening for Genetic Disorders in the Fetus, By Region, 2017-2022 (US$ Mn)
TABLE 16 Global  Rare Disease Genetic Testing Market, by Screening for Genetic Disorders in the Fetus, By Region, 2023-2030 (US$ Mn)
TABLE 17 Global  Rare Disease Genetic Testing Market, by Identifying Carriers of Genetic Mutations, By Region, 2017-2022 (US$ Mn)
TABLE 18 Global  Rare Disease Genetic Testing Market, by Identifying Carriers of Genetic Mutations, By Region, 2023-2030 (US$ Mn)
TABLE 19 Global  Rare Disease Genetic Testing Market, by Confirmatory Testing, By Region, 2017-2022 (US$ Mn)
TABLE 20 Global  Rare Disease Genetic Testing Market, by Confirmatory Testing, By Region, 2023-2030 (US$ Mn)
TABLE 21 Global  Rare Disease Genetic Testing Market, by Comprehensive Diagnostic Testing, By Region, 2017-2022 (US$ Mn)
TABLE 22 Global  Rare Disease Genetic Testing Market, by Comprehensive Diagnostic Testing, By Region, 2023-2030 (US$ Mn)
TABLE 23 Global  Rare Disease Genetic Testing Market, by Screening Embryos for Genetic Abnormalities, By Region, 2017-2022 (US$ Mn)
TABLE 24 Global  Rare Disease Genetic Testing Market, by Screening Embryos for Genetic Abnormalities, By Region, 2023-2030 (US$ Mn)
TABLE 25 Global  Rare Disease Genetic Testing Market, by Consumer-Initiated Genetic Testing Services, By Region, 2017-2022 (US$ Mn)
TABLE 26 Global  Rare Disease Genetic Testing Market, by Consumer-Initiated Genetic Testing Services, By Region, 2023-2030 (US$ Mn)
TABLE 27 Global  Rare Disease Genetic Testing Market, by Microarray Technology, By Region, 2017-2022 (US$ Mn)
TABLE 28 Global  Rare Disease Genetic Testing Market, by Microarray Technology, By Region, 2023-2030 (US$ Mn)
TABLE 29 Global  Rare Disease Genetic Testing Market, by Microarray PCR (Polymerase Chain Reaction), By Region, 2017-2022 (US$ Mn)
TABLE 30 Global  Rare Disease Genetic Testing Market, by Microarray PCR (Polymerase Chain Reaction), By Region, 2023-2030 (US$ Mn)
TABLE 31 Global  Rare Disease Genetic Testing Market, by Interpretation Services, By Region, 2017-2022 (US$ Mn)
TABLE 32 Global  Rare Disease Genetic Testing Market, by Interpretation Services, By Region, 2023-2030 (US$ Mn)
TABLE 33 Global  Rare Disease Genetic Testing Market, by Data Storage and Management, By Region, 2017-2022 (US$ Mn)
TABLE 34 Global  Rare Disease Genetic Testing Market, by Data Storage and Management, By Region, 2023-2030 (US$ Mn)
TABLE 35 Global  Rare Disease Genetic Testing Market, by Hospitals and Clinics, By Region, 2017-2022 (US$ Mn)
TABLE 36 Global  Rare Disease Genetic Testing Market, by Hospitals and Clinics, By Region, 2023-2030 (US$ Mn)
TABLE 37 Global  Rare Disease Genetic Testing Market, by Genetic Testing Laboratories, By Region, 2017-2022 (US$ Mn)
TABLE 38 Global  Rare Disease Genetic Testing Market, by Genetic Testing Laboratories, By Region, 2023-2030 (US$ Mn)
TABLE 39 Global  Rare Disease Genetic Testing Market, by Direct-to-Consumer Companies, By Region, 2017-2022 (US$ Mn)
TABLE 40 Global  Rare Disease Genetic Testing Market, by Direct-to-Consumer Companies, By Region, 2023-2030 (US$ Mn)
TABLE 41 Global  Rare Disease Genetic Testing Market, by Compliance with Regulatory Standards, By Region, 2017-2022 (US$ Mn)
TABLE 42 Global  Rare Disease Genetic Testing Market, by Compliance with Regulatory Standards, By Region, 2023-2030 (US$ Mn)
TABLE 43 Global  Rare Disease Genetic Testing Market, by Industry and Academic Collaborations, By Region, 2017-2022 (US$ Mn)
TABLE 44 Global  Rare Disease Genetic Testing Market, by Industry and Academic Collaborations, By Region, 2023-2030 (US$ Mn)
TABLE 45 Global  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 46 Global  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 47 Global  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 48 Global  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 49 Global  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 50 Global  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 51 Global  Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 52 Global  Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 53 Global  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 54 Global  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 55 Global  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2023-2030 (US$ Mn)
TABLE 56 Global  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 57 Global  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 58 Global  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 59 Global  Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 60 Global  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 61 Global  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 62 Global  Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 63 Global  Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 64 Global  Rare Disease Genetic Testing Market, by Region, 2017-2022 (US$ Mn)
TABLE 65 Global  Rare Disease Genetic Testing Market, by Region, 2023-2030 (US$ Mn)
TABLE 66 North America  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 67 North America  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 68 North America  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 69 North America  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 70 North America  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 71 North America  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 72 North America Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 73 North America Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 74 North America Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 75 North America Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 76 North America  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 77 North America  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2023-2030 (US$ Mn)
TABLE 78 North America  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 79 North America  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 80 North America  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 81 North America  Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 82 North America Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 83 North America Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 84 North America Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 85 North America Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 86 North America  Rare Disease Genetic Testing Market, by Country, 2017-2022 (US$ Mn)
TABLE 87 North America  Rare Disease Genetic Testing Market, by Country, 2023-2030 (US$ Mn)
TABLE 88 United States  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 89 United States  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 90 United States  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 91 United States  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 92 United States  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 93 United States  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 94 United States Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 95 United States Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 96 United States Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 97 United States Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 98 United States  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 99 United States  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2023-2030 (US$ Mn)
TABLE 100 United States  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 101 United States  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 102 United States  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 103 United States  Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 104 United States  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 105 United States  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 106 United States  Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 107 United States  Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 108 Canada  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 109 Canada  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 110 Canada  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 111 Canada  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 112 Canada  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 113 Canada  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 114 Canada Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 115 Canada Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 116 Canada Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 117 Canada  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 118 Canada  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 119 Canada  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2023-2030 (US$ Mn)
TABLE 120 Canada  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 121 Canada  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 122 Canada  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 123 Canada  Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 124 Canada  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 125 Canada  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 126 Canada  Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 127 Canada  Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 128 Mexico  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 129 Mexico  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 130 Mexico  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 131 Mexico  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 132 Mexico  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 133 Mexico  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 134 Mexico Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 135 Mexico Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 136 Mexico Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 137 Mexico  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 138 Mexico  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 139 Mexico  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2023-2030 (US$ Mn)
TABLE 140 Mexico  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 141 Mexico  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 142 Mexico  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 143 Mexico  Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 144 Mexico  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 145 Mexico  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 146 Mexico  Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 147 Mexico  Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 148 Europe  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 149 Europe  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 150 Europe  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 151 Europe  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 152 Europe  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 153 Europe  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 154 Europe Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 155 Europe Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 156 Europe Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 157 Europe Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 158 Europe  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 159 Europe  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2023-2030 (US$ Mn)
TABLE 160 Europe  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 161 Europe  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 162 Europe  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 163 Europe  Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 164 Europe  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 165 Europe  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 166 Europe  Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 167 Europe  Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 168 Europe  Rare Disease Genetic Testing Market, by Country, 2017-2022 (US$ Mn)
TABLE 169 Europe  Rare Disease Genetic Testing Market, by Country, 2023-2030 (US$ Mn)
TABLE 170 Germany  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 171 Germany  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 172 Germany  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 173 Germany  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 174 Germany  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 175 Germany  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 176 Germany Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 177 Germany Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 178 Germany Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 179 Germany  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 180 Germany  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 181 Germany  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2023-2030 (US$ Mn)
TABLE 182 Germany  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 183 Germany  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 184 Germany  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 185 Germany  Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 186 Germany  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 187 Germany  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 188 Germany  Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 189 Germany  Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 190 France  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 191 France  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 192 France  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 193 France  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 194 France  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 195 France  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 196 France Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 197 France Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 198 France Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 199 France  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 200 France  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 201 France  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2023-2030 (US$ Mn)
TABLE 202 France  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 203 France  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 204 France  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 205 France  Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 206 France  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 207 France  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 208 France  Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 209 France  Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 210 United Kingdom  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 211 United Kingdom  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 212 United Kingdom  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 213 United Kingdom  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 214 United Kingdom  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 215 United Kingdom  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 216 United Kingdom Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 217 United Kingdom Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 218 United Kingdom Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 219 United Kingdom  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 220 United Kingdom  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 221 United Kingdom  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2023-2030 (US$ Mn)
TABLE 222 United Kingdom  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 223 United Kingdom  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 224 United Kingdom  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 225 United Kingdom  Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 226 United Kingdom  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 227 United Kingdom  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 228 United Kingdom  Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 229 United Kingdom  Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 230 Italy  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 231 Italy  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 232 Italy  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 233 Italy  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 234 Italy  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 235 Italy  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 236 Italy Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 237 Italy Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 238 Italy Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 239 Italy  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 240 Italy  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 241 Italy  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2023-2030 (US$ Mn)
TABLE 242 Italy  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 243 Italy  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 244 Italy  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 245 Italy  Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 246 Italy  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 247 Italy  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 248 Italy  Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 249 Italy  Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 250 Spain  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 251 Spain  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 252 Spain  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 253 Spain  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 254 Spain  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 255 Spain  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 256 Spain Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 257 Spain Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 258 Spain Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 259 Spain  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 260 Spain  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 261 Spain  Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 262 Spain  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 263 Spain  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 264 Spain  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 265 Spain  Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 266 Spain  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 267 Spain  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 268 Spain  Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 269 Spain  Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 270 Benelux Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 271 Benelux Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 272 Benelux Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 273 Benelux Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 274 Benelux Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 275 Benelux Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 276 Benelux Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 277 Benelux Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 278 Benelux Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 279 Benelux  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 280 Benelux  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 281 Benelux  Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 282 Benelux  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 283 Benelux  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 284 Benelux  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 285 Benelux  Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 286 Benelux  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 287 Benelux  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 288 Benelux  Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 289 Benelux  Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 290 Russia Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 291 Russia Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 292 Russia Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 293 Russia Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 294 Russia Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 295 Russia Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 296 Russia Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 297 Russia Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 298 Russia Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 299 Russia  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 300 Russia  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 301 Russia  Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 302 Russia  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 303 Russia  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 304 Russia  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 305 Russia  Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 306 Russia  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 307 Russia  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 308 Russia  Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 309 Russia  Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 310 Rest of Europe  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 311 Rest of Europe  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 312 Rest of Europe  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 313 Rest of Europe  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 314 Rest of Europe  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 315 Rest of Europe  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 316 Rest of Europe Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 317 Rest of Europe Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 318 Rest of Europe Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 319 Rest of Europe  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 320 Rest of Europe  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 321 Rest of Europe  Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 322 Rest of Europe  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 323 Rest of Europe  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 324 Rest of Europe  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 325 Rest of Europe  Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 326 Rest of Europe  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 327 Rest of Europe  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 328 Rest of Europe  Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 329 Rest of Europe  Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 330 Asia Pacific  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 331 Asia Pacific  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 332 Asia Pacific  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 333 Asia Pacific  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 334 Asia Pacific  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 335 Asia Pacific  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 336 Asia Pacific Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 337 Asia Pacific Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 338 Asia Pacific Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 339 Asia Pacific  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 340 Asia Pacific  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 341 Asia Pacific  Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 342 Asia Pacific  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 343 Asia Pacific  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 344 Asia Pacific  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 345 Asia Pacific  Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 346 Asia Pacific  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 347 Asia Pacific  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 348 Asia Pacific  Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 349 Asia Pacific  Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 350 China  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 351 China  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 352 China  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 353 China  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 354 China  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 355 China  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 356 China Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 357 China Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 358 China Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 359 China  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 360 China  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 361 China  Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 362 China  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 363 China  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 364 China  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 365 China  Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 366 China  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 367 China  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 368 China  Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 369 China  Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 370 Japan  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 371 Japan  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 372 Japan  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 373 Japan  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 374 Japan  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 375 Japan  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 376 Japan Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 377 Japan Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 378 Japan Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 379 Japan  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 380 Japan  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 381 Japan  Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 382 Japan  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 383 Japan  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 384 Japan  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 385 Japan  Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 386 Japan  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 387 Japan  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 388 Japan  Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 389 Japan  Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 390 India  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 391 India  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 392 India  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 393 India  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 394 India  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 395 India  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 396 India Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 397 India Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 398 India Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 399 India  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 400 India  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 401 India  Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 402 India  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 403 India  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 404 India  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 405 India  Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 406 India  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 407 India  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 408 India  Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 409 India  Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 410 South Korea  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 411 South Korea  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 412 South Korea  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 413 South Korea  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 414 South Korea  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 415 South Korea  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 416 South Korea Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 417 South Korea Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 418 South Korea Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 419 South Korea  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 420 South Korea  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 421 South Korea  Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 422 South Korea  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 423 South Korea  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 424 South Korea  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 425 South Korea  Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 426 South Korea  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 427 South Korea  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 428 South Korea  Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 429 South Korea  Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 430 South-East Asia  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 431 South-East Asia  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 432 South-East Asia  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 433 South-East Asia  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 434 South-East Asia  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 435 South-East Asia  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 436 South-East Asia Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 437 South-East Asia Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 438 South-East Asia Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 439 South-East Asia  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 440 South-East Asia  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 441 South-East Asia  Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 442 South-East Asia  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 443 South-East Asia  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 444 South-East Asia  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 445 South-East Asia  Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 446 South-East Asia  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 447 South-East Asia  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 448 South-East Asia  Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 449 South-East Asia  Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 450 Rest of Asia Pacific  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 451 Rest of Asia Pacific  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 452 Rest of Asia Pacific  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 453 Rest of Asia Pacific  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 454 Rest of Asia Pacific  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 455 Rest of Asia Pacific  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 456 Rest of Asia Pacific Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 457 Rest of Asia Pacific Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 458 Rest of Asia Pacific  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 459 Rest of Asia Pacific Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 460 Rest of Asia Pacific  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 461 Rest of Asia Pacific  Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 462 Rest of Asia Pacific  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 463 Rest of Asia Pacific  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 464 Rest of Asia Pacific  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 465 Rest of Asia Pacific  Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 466 Rest of Asia Pacific  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 467 Rest of Asia Pacific  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 468 Rest of Asia Pacific  Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 469 Rest of Asia Pacific  Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 470 Latin America  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 471 Latin America  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 472 Latin America  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 473 Latin America  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 474 Latin America  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 475 Latin America  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 476 Latin America Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 477 Latin America Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 478 Latin America Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 479 Latin America  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 480 Latin America  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 481 Latin America  Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 482 Latin America  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 483 Latin America  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 484 Latin America  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 485 Latin America  Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 486 Latin America  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 487 Latin America  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 488 Latin America  Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 489 Latin America  Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 490 Brazil  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 491 Brazil  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 492 Brazil  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 493 Brazil  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 494 Brazil  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 495 Brazil  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 496 Brazil Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 497 Brazil Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 498 Brazil Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 499 Brazil  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 500 Brazil  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 501 Brazil  Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 502 Brazil  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 503 Brazil  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 504 Brazil  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 505 Brazil  Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 506 Brazil  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 507 Brazil  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 508 Brazil  Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 509 Brazil  Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 510 Argentina  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 511 Argentina  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 512 Argentina  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 513 Argentina  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 514 Argentina  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 515 Argentina  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 516 Argentina Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 517 Argentina Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 518 Argentina Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 519 Argentina  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 520 Argentina  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 521 Argentina  Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 522 Argentina  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 523 Argentina  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 524 Argentina  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 525 Argentina  Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 526 Argentina  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 527 Argentina  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 528 Argentina  Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 529 Argentina  Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 530 Rest of Latin America  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 531 Rest of Latin America  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 532 Rest of Latin America  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 533 Rest of Latin America  Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 534 Rest of Latin America  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 535 Rest of Latin America  Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 536 Rest of Latin America Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 537 Rest of Latin America Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 538 Rest of Latin America Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 539 Rest of Latin America  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 540 Rest of Latin America  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 541 Rest of Latin America  Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 542 Rest of Latin America  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 543 Rest of Latin America  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 544 Rest of Latin America  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 545 Rest of Latin America  Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 546 Rest of Latin America  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 547 Rest of Latin America  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 548 Rest of Latin America  Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 549 Rest of Latin America  Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 550 Middle East Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 551 Middle East Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 552 Middle East Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 553 Middle East Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 554 Middle East Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 555 Middle East Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 556 Middle East Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 557 Middle East Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 558 Middle East Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 559 Middle East  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 560 Middle East  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 561 Middle East  Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 562 Middle East  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 563 Middle East  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 564 Middle East  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 565 Middle East  Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 566 Middle East  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 567 Middle East  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 568 Middle East  Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 569 Middle East  Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 570 UAE Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 571 UAE Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 572 UAE Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 573 UAE Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 574 UAE Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 575 UAE Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 576 UAE Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 577 UAE Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 578 UAE Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 579 UAE  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 580 UAE  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 581 UAE  Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 582 UAE  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 583 UAE  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 584 UAE  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 585 UAE  Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 586 UAE  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 587 UAE  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 588 UAE  Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 589 UAE  Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 590 Saudi Arabia Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 591 Saudi Arabia Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 592 Saudi Arabia Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 593 Saudi Arabia Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 594 Saudi Arabia Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 595 Saudi Arabia Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 596 Saudi Arabia Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 597 Saudi Arabia Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 598 Saudi Arabia Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 599 Saudi Arabia  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 600 Saudi Arabia  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 601 Saudi Arabia  Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 602 Saudi Arabia  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 603 Saudi Arabia  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 604 Saudi Arabia  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 605 Saudi Arabia  Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 606 Saudi Arabia  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 607 Saudi Arabia  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 608 Saudi Arabia  Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 609 Saudi Arabia  Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 610 Rest of Middle East Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 611 Rest of Middle East Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 612 Rest of Middle East Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 613 Rest of Middle East Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 614 Rest of Middle East Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 615 Rest of Middle East Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 616 Rest of Middle East Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 617 Rest of Middle East Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 618 Rest of Middle East Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 619 Rest of Middle East  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 620 Rest of Middle East  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 621 Rest of Middle East  Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 622 Rest of Middle East  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 623 Rest of Middle East  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 624 Rest of Middle East  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 625 Rest of Middle East  Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 626 Rest of Middle East  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 627 Rest of Middle East  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 628 Rest of Middle East  Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 629 Rest of Middle East  Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 630 Africa  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 631 Africa Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 632 Africa Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 633 Africa Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 634 Africa Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 635 Africa Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 636 Africa Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 637 Africa Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 638 Africa Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 639 Africa  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 640 Africa  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 641 Africa  Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 642 Africa  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 643 Africa  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 644 Africa  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 645 Africa  Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 646 Africa  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 647 Africa  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 648 Africa  Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 649 Africa  Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 650 South Africa  Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 651 South Africa Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 652 South Africa Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 653 South Africa Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 654 South Africa Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 655 South Africa Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 656 South Africa Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 657 South Africa Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 658 South Africa Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 659 South Africa  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 660 South Africa  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 661 South Africa  Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 662 South Africa  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 663 South Africa  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 664 South Africa  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 665 South Africa  Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 666 South Africa  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 667 South Africa  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 668 South Africa  Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 669 South Africa  Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 670 Egypt Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 671 Egypt Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 672 Egypt Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 673 Egypt Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 674 Egypt Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 675 Egypt Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 676 Egypt Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 677 Egypt Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 678 Egypt Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 679 Egypt  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 680 Egypt  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 681 Egypt  Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 682 Egypt  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 683 Egypt  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 684 Egypt  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 685 Egypt  Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 686 Egypt  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 687 Egypt  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 688 Egypt  Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 689 Egypt  Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 690 Rest of Africa Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 691 Rest of Africa Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 692 Rest of Africa Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 693 Rest of Africa Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 694 Rest of Africa Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 695 Rest of Africa Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 696 Rest of Africa Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 697 Rest of Africa Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 698 Rest of Africa Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 699 Rest of Africa  Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 700 Rest of Africa  Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 701 Rest of Africa  Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 702 Rest of Africa  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 703 Rest of Africa  Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 704 Rest of Africa  Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 705 Rest of Africa  Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 706 Rest of Africa  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 707 Rest of Africa  Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 708 Rest of Africa  Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
What is the current Targeted Genetic Testing of the worldwide Rare Disease Genetic Testing Market?

In 2022, the global Rare Disease Genetic Testing Market is expected to be worth USD 894.8million.

What is the predicted growth rate of the Rare Disease Genetic Testing Market between 2023 and 2030?

The Rare Disease Genetic Testing Market is estimated to increase at a CAGR of 15.20% between 2023 and 2030, reaching USD 2775.5 Million in 2030.

Which segment has the most market share in terms of end-Users?

In 2022, Hospitals and clinics have a bigger market share

Which Targeted Genetic Testing segment governs the market demand for Rare Disease Genetic Testing?

Panel Testing is the market demand sector that governs the market.

What are the major market restraints of the Rare Disease Genetic Testing industry?

The primary market restraints are ethical and privacy concerns associated to genetic testing, as well as a complex regulatory framework and reimbursement challenges.

US Addiction Treatment Market

Published:
Report ID: 43690

Gastric Electric Simulator Market

Published:
Report ID: 43506

Skin Lightening Lip Balm Market

Published:
Report ID: 43513

Critical Care Patient Monitoring Products Market

Published:
Report ID: 43479

Gaucher Disease Therapeutics Market

Published:
Report ID: 12699

Wound Filler Market

Published:
Report ID: 43323

Liposuction Market

Published:
Report ID: 43308

Australia Addiction Treatment Market

Published:
Report ID: 43261

Asia Pacific Addiction Treatment Market

Published:
Report ID: 43270

Wound Wash Market

Published:
Report ID: 43199

Obesity Diabetes Drugs Market

Published:
Report ID: 43145

Breast Reconstruction Meshes Market

Published:
Report ID: 43131

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN